# Carbidopa-Levodopa in Dry AMD With Geographic Atrophy

> **NCT03451500** · PHASE2 · TERMINATED · sponsor: **Snyder, Robert W., M.D., Ph.D., P.C.** · enrollment: 7 (actual)

## Conditions studied

- Age Related Macular Degeneration

## Interventions

- **DRUG:** carbidopa-levodopa

## Key facts

- **NCT ID:** NCT03451500
- **Lead sponsor:** Snyder, Robert W., M.D., Ph.D., P.C.
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-07-01
- **Primary completion:** 2019-10-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Lack of funding required for enrollment to reach statistical significance.
- **Last updated:** 2024-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03451500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03451500, "Carbidopa-Levodopa in Dry AMD With Geographic Atrophy". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03451500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*